NCT05019820

Brief Summary

The aim of this thesis; To define sarcopenia in knee osteoarthritis with ultrasonography and to evaluate changes in muscle structure in sarcopenia after isokinetic exercise application ultrasonographically. The investigators will evaluate the effect of isokinetic exercise therapy in sarcopenic patients with knee osteoarthritis with VAS (Visual Analog Scale) and WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index). Then, the hand grip strength will be evaluated with a dynamometer, and its effects on physical performance will be evaluated by 6 meters walking and chair rising tests.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2021

Completed
26 days until next milestone

Study Start

First participant enrolled

August 18, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 25, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2021

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2022

Completed
Last Updated

August 25, 2021

Status Verified

August 1, 2021

Enrollment Period

3 months

First QC Date

July 23, 2021

Last Update Submit

August 19, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Muscle architecture

    Determination of muscle architecture change with ultrasonography after isokinetic exercise

    Six weeks

Secondary Outcomes (5)

  • Knee pain

    Six weeks

  • Functional status

    Six weeks

  • Hand grip strength

    Six weeks

  • Walking speed

    Six weeks

  • Time to get out of the chair

    Six weeks

Study Arms (2)

Sarcopenia and osteoarthritis group

ACTIVE COMPARATOR

Women aged 45-65 years diagnosed with sarcopenia and knee osteoarthritis

Other: Knee strengthening exercises with isokinetic dynamometer

Without osteoarthritis and sarcopenia group

OTHER

Women aged 45-65 years without a diagnosis of knee osteoarthritis and sarcopenia

Other: Strengthening around the knees with home exercise programe

Interventions

18 sessions of strengthening exercises around the knee with an isokinetic dynamometer 3 days a week

Sarcopenia and osteoarthritis group

18 sessions of strengthening exercises for the muscles around the knee at home, 3 days a week

Without osteoarthritis and sarcopenia group

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Among the 45-65 age group, 30 female patients diagnosed with knee osteoarthritis (Stage 1-2-3) and sarcopenia together
  • Among the 45-65 age group, 30 females without osteoarthritis and sarcopenia will be included in the study as the control group.

You may not qualify if:

  • Diabetes Mellitus,
  • Severe Coronary Artery Disease / Congestive Heart Failure,
  • Severe Liver Failure,
  • Neuromuscular disease,
  • Lower extremity surgery,
  • Rheumatological disease,
  • Those who use walking aids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hatay Mustafa Kemal University

Hatay, Antakya, 31000, Turkey (Türkiye)

RECRUITING

Related Publications (7)

  • Spinoso DH, Bellei NC, Marques NR, Navega MT. Quadriceps muscle weakness influences the gait pattern in women with knee osteoarthritis. Adv Rheumatol. 2018 Aug 31;58(1):26. doi: 10.1186/s42358-018-0027-7.

    PMID: 30657091BACKGROUND
  • Lange AK, Vanwanseele B, Fiatarone Singh MA. Strength training for treatment of osteoarthritis of the knee: a systematic review. Arthritis Rheum. 2008 Oct 15;59(10):1488-94. doi: 10.1002/art.24118.

    PMID: 18821647BACKGROUND
  • Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.

    PMID: 30312372BACKGROUND
  • Kara M, Kaymak B, Ata AM, Ozkal O, Kara O, Baki A, Sengul Aycicek G, Topuz S, Karahan S, Soylu AR, Cakir B, Halil M, Ozcakar L. STAR-Sonographic Thigh Adjustment Ratio: A Golden Formula for the Diagnosis of Sarcopenia. Am J Phys Med Rehabil. 2020 Oct;99(10):902-908. doi: 10.1097/PHM.0000000000001439.

    PMID: 32941253BACKGROUND
  • Papalia R, Zampogna B, Torre G, Lanotte A, Vasta S, Albo E, Tecame A, Denaro V. Sarcopenia and its relationship with osteoarthritis: risk factor or direct consequence? Musculoskelet Surg. 2014 Jun;98(1):9-14. doi: 10.1007/s12306-014-0311-6. Epub 2014 Jan 31.

    PMID: 24482109BACKGROUND
  • Baroni BM, Geremia JM, Rodrigues R, De Azevedo Franke R, Karamanidis K, Vaz MA. Muscle architecture adaptations to knee extensor eccentric training: rectus femoris vs. vastus lateralis. Muscle Nerve. 2013 Oct;48(4):498-506. doi: 10.1002/mus.23785. Epub 2013 Jul 15.

    PMID: 23852989BACKGROUND
  • Lespasio MJ, Piuzzi NS, Husni ME, Muschler GF, Guarino A, Mont MA. Knee Osteoarthritis: A Primer. Perm J. 2017;21:16-183. doi: 10.7812/TPP/16-183.

MeSH Terms

Conditions

Osteoarthritis, KneeSarcopenia

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 23, 2021

First Posted

August 25, 2021

Study Start

August 18, 2021

Primary Completion

November 20, 2021

Study Completion

December 13, 2022

Last Updated

August 25, 2021

Record last verified: 2021-08

Locations